PNTG · Pennant Group, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $285.36M | - | $229.04M | $219.50M | $209.84M | - | $180.69M | $168.75M | $156.91M | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $19.69M | - | $19.30M | $17.60M | $14.84M | - | $13.02M | $11.88M | $11.44M | - |
| Total Operating Expenses | $268.06M | - | $218.80M | $207.97M | $197.19M | - | $169.89M | $159.18M | $148.39M | - |
| D&A | $2.62M | - | $2.06M | $2.22M | $1.89M | - | $1.49M | $1.47M | $1.33M | - |
| Operating Income | $17.30M | - | $10.24M | $11.53M | $12.65M | - | $10.79M | $9.56M | $8.52M | - |
| Interest Expense | $3.07M | - | $1.02M | $1.20M | $1.79M | - | $2.89M | $1.45M | $1.79M | - |
| Income Tax | $3.79M | - | $2.52M | $2.60M | $2.85M | - | $1.35M | $1.84M | $1.76M | - |
| Net Income | $8.52M | - | $6.08M | $7.08M | $7.78M | - | $6.21M | $5.69M | $4.91M | - |
| EPS - Basic | $0.25 | - | $0.18 | $0.21 | $0.23 | - | $0.20 | $0.19 | $0.16 | - |
| EPS - Diluted | $0.24 | - | $0.17 | $0.20 | $0.22 | - | $0.20 | $0.18 | $0.16 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.91M | $17.02M | $2.34M | $14.38M | $5.22M | $24.25M | $4.46M | $3.04M | $2.72M | $6.06M |
| Accounts Receivable | $122.82M | $123.11M | $96.08M | $95.72M | $94.99M | $81.30M | $84.03M | $76.09M | $71.35M | $61.12M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $22.80M | $25.17M | $21.63M | $19.21M | $18.80M | $18.74M | $15.89M | $15.39M | $13.06M | $10.84M |
| Current Assets | $152.82M | $167.41M | $113.97M | $127.37M | $123.89M | $122.86M | $101.80M | $94.11M | $87.06M | $80.08M |
| Total Assets | $956.48M | $968.18M | $753.64M | $751.42M | $743.62M | $679.52M | $646.76M | $602.47M | $578.24M | $539.69M |
| Current Liabilities | $128.57M | $147.26M | $109.35M | $104.94M | $87.97M | $101.70M | $90.59M | $83.69M | $75.23M | $71.55M |
| Long-term Debt | $164.67M | $168.84M | $26.00M | $37.00M | $52.50M | $0 | $108.88M | $82.17M | $83.29M | $63.91M |
| Total Liabilities | $567.05M | $593.93M | $410.60M | $417.79M | $420.60M | $367.56M | $459.47M | $429.47M | $414.01M | $394.18M |
| Stockholders' Equity | $389.44M | $374.25M | $343.04M | $333.63M | $323.03M | $311.96M | $187.29M | $172.99M | $164.23M | $145.51M |
| Retained Earnings | $95.32M | $86.80M | $78.16M | $72.08M | $65.00M | $57.22M | $51.46M | $45.26M | $39.57M | $34.66M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($3.40M) | - | - | - | ($21.23M) | - | - | - | $545.0K | - |
| Investing Cash Flow | ($5.38M) | - | - | - | ($50.30M) | - | - | - | ($23.64M) | - |
| Financing Cash Flow | ($3.33M) | - | - | - | $52.51M | - | - | - | $19.75M | - |
| CapEx | $5.27M | - | - | - | $1.96M | - | - | - | $3.14M | - |
| Free Cash Flow | ($8.68M) | - | - | - | ($23.19M) | - | - | - | ($2.60M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | 6.1% | - | 4.5% | 5.3% | 6.0% | - | 6.0% | 5.7% | 5.4% | - |
| EBITDA margin | 7.0% | - | 5.4% | 6.3% | 6.9% | - | 6.8% | 6.5% | 6.3% | - |
| Net margin | 3.0% | - | 2.7% | 3.2% | 3.7% | - | 3.4% | 3.4% | 3.1% | - |
| Free cash flow margin | -3.0% | - | - | - | -11.1% | - | - | - | -1.7% | - |
| FCF / Net income | -1.02 | - | - | - | -2.98 | - | - | - | -0.53 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 6.9% | - | 8.4% | 8.0% | 7.1% | - | 7.2% | 7.0% | 7.3% | - |
| Effective tax rate | 30.8% | - | 29.3% | 26.8% | 26.9% | - | 17.9% | 24.5% | 26.4% | - |
| Return on assets | 0.9% | - | 0.8% | 0.9% | 1.0% | - | 1.0% | 0.9% | 0.8% | - |
| Return on equity | 2.2% | - | 1.8% | 2.1% | 2.4% | - | 3.3% | 3.3% | 3.0% | - |
| Return on invested capital | 2.2% | - | 2.0% | 2.3% | 2.5% | - | 3.0% | 2.8% | 2.5% | - |
| Liquidity | ||||||||||
| Current ratio | 1.19 | 1.14 | 1.04 | 1.21 | 1.41 | 1.21 | 1.12 | 1.12 | 1.16 | 1.12 |
| Quick ratio | 1.19 | 1.14 | 1.04 | 1.21 | 1.41 | 1.21 | 1.12 | 1.12 | 1.16 | 1.12 |
| Cash ratio | 0.04 | 0.12 | 0.02 | 0.14 | 0.06 | 0.24 | 0.05 | 0.04 | 0.04 | 0.08 |
| Leverage | ||||||||||
| Debt / Equity | 0.42 | 0.45 | 0.08 | 0.11 | 0.16 | 0.00 | 0.58 | 0.48 | 0.51 | 0.44 |
| Debt / Assets | 0.17 | 0.17 | 0.03 | 0.05 | 0.07 | 0.00 | 0.17 | 0.14 | 0.14 | 0.12 |
| Debt / EBITDA | 8.27 | - | 2.11 | 2.69 | 3.61 | - | 8.86 | 7.45 | 8.45 | - |
| Interest coverage | 5.6x | - | 10.1x | 9.6x | 7.1x | - | 3.7x | 6.6x | 4.8x | - |
| Equity multiplier | 2.46 | 2.59 | 2.20 | 2.25 | 2.30 | 2.18 | 3.45 | 3.48 | 3.52 | 3.71 |
| Liabilities / Assets | 0.59 | 0.61 | 0.54 | 0.56 | 0.57 | 0.54 | 0.71 | 0.71 | 0.72 | 0.73 |
| Efficiency | ||||||||||
| Asset turnover | 0.30 | - | 0.30 | 0.29 | 0.28 | - | 0.28 | 0.28 | 0.27 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 157d | - | 153d | 159d | 165d | - | 170d | 165d | 166d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 127.0x | - | 148.4x | 149.3x | 114.3x | - | 178.5x | 128.8x | 122.7x | - |
| P / B | 2.8x | - | 2.6x | 3.2x | 2.7x | - | 6.0x | 4.1x | 3.6x | - |
| P / S | 3.8x | - | 3.9x | 4.8x | 4.2x | - | 6.2x | 4.2x | 3.8x | - |
| EV / EBITDA | 62.7x | - | 74.2x | 78.4x | 64.1x | - | 99.6x | 71.9x | 68.7x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 36.0% | - | 26.8% | 30.1% | 33.7% | - | 28.9% | 27.6% | 24.1% | - |
| Revenue CAGR (3y) | 31.2% | - | 24.6% | 23.6% | 22.6% | - | 17.3% | 15.2% | 14.1% | - |
| Revenue CAGR (5y) | 22.0% | - | 18.4% | 21.5% | 18.0% | - | 19.9% | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 36.8% | - | -5.2% | 20.6% | 48.4% | - | 52.9% | 52.7% | 99.2% | - |
| Net income growth (YoY) | 9.6% | - | -2.0% | 24.5% | 58.5% | - | 41.6% | 103.4% | 165.2% | - |
| EPS growth (YoY) | 9.1% | - | -15.0% | 11.1% | 37.5% | - | 33.3% | 100.0% | 166.7% | - |
| EPS CAGR (3y) | 58.7% | - | 2.0% | - | 94.3% | - | 71.0% | 26.0% | 74.7% | - |
| EPS CAGR (5y) | 51.6% | - | 2.5% | 5.9% | 17.1% | - | - | - | - | - |
| FCF growth (YoY) | 62.6% | - | - | - | -792.2% | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 20.6% | 20.0% | 83.2% | 92.9% | 96.7% | 114.4% | 34.2% | 29.4% | 27.1% | 15.8% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$255.09M totalHome Health And Hospice Services Segment$181.79M · 71.3%
Senior Living Services Segment$73.30M · 28.7%
Peer comparison
Same SIC group: Services-Health Services
Comparing Pennant Group against the 5 most active filers in the same SIC group.